MICHAEL BARTON: Open Payments
NPI 1609855428 · VESTAL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,008 in 96 payments from 15 companies in 2025. Trend: 2023 $478 · 2024 $1,155 · 2025 $2,008
Food & beverage: $1,898Education: $110
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $538 |
| ABBVIE INC. | 25 | $459 |
| Lilly USA, LLC | 8 | $152 |
| Galderma Laboratories, L.P. | 12 | $142 |
| UCB, Inc. | 5 | $117 |
| Novartis Pharmaceuticals Corporation | 5 | $117 |
| GENZYME CORPORATION | 5 | $116 |
| PFIZER INC. | 3 | $75 |
| E.R. Squibb & Sons, L.L.C. | 4 | $67 |
| Amgen Inc. | 2 | $59 |
Products named: TREMFYA, SKYRIZI, NEMLUVIO, TALTZ, Bimzelx, DUPIXENT, Rhapsido, Sotyktu.
Industry payments across NY — which companies pay providers there.
